EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Towards Stem/Progenitor Cell-Based Therapies for Retinal Degeneration

Hui Liu, Shuaiyan Lu, Ming Chen, Na Gao, Yuhe Yang, Huijuan Hu, Qing Ren, Xiaoyu Liu, Hongxu Chen, Qunyan Zhu, Shasha Li, Jianzhong Su iD

Stem Cell Reviews and Reports · 2024

DOI: 10.1007/s12015-024-10740-4 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Stem Cell Reviews and Reports, 2024. Verfasst von Hui Liu und 11 weiteren Autor:innen. Beteiligte Einrichtung: National Engineering Research Center of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027, China. Hauptthemen laut MEDLINE: Retinal Degeneration, Stem Cell Transplantation. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 146 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Zhejiang Provincial Natural Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Retinal degeneration (RD) is a leading cause of blindness worldwide and includes conditions such as retinitis pigmentosa (RP), age-related macular degeneration (AMD), and Stargardt's disease (STGD). These diseases result in the permanent loss of vision due to the progressive and irreversible degeneration of retinal cells, including photoreceptors (PR) and the retinal pigment epithelium (RPE). The adult human retina has limited abilities to regenerate and repair itself, making it challenging to achieve complete self-replenishment and functional repair of retinal cells. Currently, there is no effective clinical treatment for RD. Stem cell therapy, which involves transplanting exogenous stem cells such as retinal progenitor cells (RPCs), embryonic stem cells (ESCs), induced pluripotent stem cells (iPSCs), and mesenchymal stem cells (MSCs), or activating endogenous stem cells like Müller Glia (MG) cells, holds great promise for regenerating and repairing retinal cells in the treatment of RD. Several preclinical and clinical studies have shown the potential of stem cell-based therapies for RD. However, the clinical translation of these therapies for the reconstruction of substantial vision still faces significant challenges. This review provides a comprehensive overview of stem/progenitor cell-based therapy strategies for RD, summarizes recent advances in preclinical studies and clinical trials, and highlights the major challenges in using stem/progenitor cell-based therapies for RD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Retinal DegenerationStem Cell TransplantationHumansAnimalsStem CellsCell- and Tissue-Based TherapyRetina

Stichwörter der Autor:innen

Clinical trialsRegenerationRetinal cellsRetinal degenerationStem cell therapyTransplantation

Autor:innen und Institutionen

  • National Engineering Research Center of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027, China.
  • State Key Laboratory of Ophthalmology, Optometry and Visual Science, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027, China.
  • Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou, Zhejiang, 325011, China.
  • National Engineering Research Center of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027, China. lishasha@ojlab.ac.cn.
  • State Key Laboratory of Ophthalmology, Optometry and Visual Science, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027, China. lishasha@ojlab.ac.cn.
  • Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), Wenzhou, 325001, China. lishasha@ojlab.ac.cn.

ORCID-Profile: Jianzhong Su

Förderung

  • National Natural Science Foundation of China
  • Zhejiang Provincial Natural Science

Zitieren

APA

Liu, H., Lu, S., Chen, M., Gao, N., Yang, Y., Hu, H., Ren, Q., Liu, X., Chen, H., Zhu, Q., Li, S., & Su, J. (2024). Towards Stem/Progenitor Cell-Based Therapies for Retinal Degeneration. Stem Cell Reviews and Reports. https://doi.org/10.1007/s12015-024-10740-4

Vancouver

Liu H, Lu S, Chen M, Gao N, Yang Y, Hu H, et al. Towards Stem/Progenitor Cell-Based Therapies for Retinal Degeneration. Stem Cell Reviews and Reports. 2024. doi:10.1007/s12015-024-10740-4

BibTeX
@article{Liu2024,
  author = {Liu, Hui and Lu, Shuaiyan and Chen, Ming and Gao, Na and Yang, Yuhe and Hu, Huijuan and Ren, Qing and Liu, Xiaoyu and Chen, Hongxu and Zhu, Qunyan and Li, Shasha and Su, Jianzhong},
  title = {Towards Stem/Progenitor Cell-Based Therapies for Retinal Degeneration},
  journal = {Stem Cell Reviews and Reports},
  year = {2024},
  doi = {10.1007/s12015-024-10740-4}
}
Kostenlos starten →